Berlin Institute of Health was founded in March 2013 by Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) in Berlin-Buch as a unique biomedical research institute. It brings together the synergetic scientific research competence of the two institutions, intensifying their long-standing project-based collaboration and creating a novel structure for translational research – in one institution. Two basic, closely interrelated questions are the focal point of the new institution: How can advances in life sciences be better converted into medical benefits such as new diagnostic, therapeutic, and preventive procedures and, in the best of cases, contribute to health? And inversely: how can clinical needs and challenges be better considered in the design of basic research?
Since the founding of MDC in 1992, it has successfully cooperated with Charité in individual and group projects. In July 2011, the two institutions signed a memorandum of understanding to work together in the form of a joint institution. With Berlin Institute of Health, a unique cooperative research institution was created in 2013. Berlin has now emerged as one of the most prominent locations internationally for advanced translational research – a center of attraction for top-level scientists and clinicians from around the world. First discussions about establishing Berlin Institute of Health were held between Germany’s former Minister of Health Annette Schavan and Berlin’s former Senator for Research Jürgen Zöllner in 2011. On 6 November 2012, plans for establishing BIH were announced by the German federal and Berlin state governments, which together signed the administrative agreement in January 2013. Two months later, on 25 March 2013, the founding agreement was signed by Charité - Universitätsmedizin Berlin, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, the German Ministry for Education and Research, the Berlin Senate Department for Education, Youth, and Science, and the Helmholtz Association of German Research Centers. Berlin Institute of Health was initially founded as an internal GbR (a partnership under civil law). Since 23 April 2015, BIH is a Körperschaft des öffentlichen rechts (KöR) and thus independent and vested with legal capacity.
The Founding Supervisory Board holds its constitutive meeting.
Evaluation of Scientific Concept
An international evaluation commission presents its assessment of the new institution’s scientific concept. The assessment is highly positive.
The Head Office begins its work.
On the basis of the scientific concept joint project groups formed by the Charité and MDC develop implementation plans for the research program.
The members of the Scientific Advisory Board are nominated.
A first funding call (for Collaborative Research Grants) is published.
The Directorate develops the research and budget plan with detailed measures and milestones.
The Scientific Advisory Board meets for its founding session.
The first Collaborative Research projects begin their activities.
The first pathfinder studies are chosen at the CRU.
The first BIH professorship "Experimentelle Herz-Kreislaufforschung" is being established.
The Berlin House of Representatives passes the "Gesetz zur Errichtung des Berliner Instituts für Gesundheitsforschung" (Legislation for the formation of the Berlin Institute of Health).
The legislation enabling the formation of the Berlin Institute of Health is passed into effect.
BIH operates as independent corporation under public law
Supervisory Board approves “BIH Strategy 2026”
Supervisory Board approves “Strategy Implementation Plan 2017–2020”